Codexis‑Axolabs mRNA Partnership Boosts Growth, Insider Sales Raise Market Concerns
Codexis partners with Axolabs to scale mRNA therapeutics, boosting clinical potential—but insider sales raise questions about market confidence and stock stability.
4 minutes to read